Licking Memorial Hospital

Licking Memorial Hospital was paid $55.82M by Medicaid between Jan 2018 and Dec 2024, across 478 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 19% of everything it billed.

33Billing provider infoLICKING MEMORIAL HOSPITAL
NEWARK, OH 43055

33aNPI1568446755assigned 12/01/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$55.82M

24GClaims1,251,783

24DCodes billed478

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#20 of 101

Median peer was paid$22.32M

This provider vs. median2.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	127,065	$4.92M
2019	111,451	$4.45M
2020	91,799	$5.87M
2021	117,180	$5.93M
2022	121,266	$6.37M
2023	397,848	$16.48M
2024incomplete	285,174	$11.81M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	19%	89,559	84,009	$10.45M
96361	Intravenous infusion, hydration; each additional hour	10%	18,430	15,611	$5.69M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.6%	34,853	31,250	$4.80M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.1%	37,942	35,438	$4.53M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	8.1%	37,002	33,421	$4.51M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.5%	16,591	14,678	$2.51M
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	2.6%	8,756	828	$1.44M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.1%	9,593	9,138	$1.17M
70450	Computed tomography, head or brain; without contrast material	2.1%	4,480	3,944	$1.17M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.0%	4,200	3,566	$1.14M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.5%	7,363	6,882	$853K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.3%	3,150	2,638	$710K

466 more codes

97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.1%	8,346	$641K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.1%	2,930	$632K
62323		<1%	1,444	$499K
80053	Comprehensive metabolic panel	<1%	29,446	$496K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,660	$482K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	3,241	$466K
64493		<1%	735	$393K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,057	$392K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	4,536	$390K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	9,936	$388K
G0378	Hospital observation service, per hour	<1%	6,189	$371K
80048	Basic metabolic panel (calcium, ionized)	<1%	45,987	$359K
27096		<1%	1,401	$356K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	876	$341K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,212	$338K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,802	$315K
81513		<1%	1,797	$279K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	1,059	$258K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	9,836	$249K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,174	$240K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	1,906	$230K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	2,705	$220K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	515	$218K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,291	$201K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	391	$186K
83036	Hemoglobin; glycosylated (A1C)	<1%	11,817	$183K
84443	Thyroid stimulating hormone (TSH)	<1%	9,892	$180K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	11,619	$169K
83655		<1%	4,932	$159K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	992	$159K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	60,101	$157K
76801		<1%	1,039	$156K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	5,728	$152K
80061	Lipid panel	<1%	9,396	$152K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,331	$143K
20552		<1%	2,033	$135K
76830	Ultrasound, transvaginal	<1%	1,182	$127K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	381	$121K
36415	Collection of venous blood by venipuncture	<1%	57,528	$117K
64494		<1%	933	$112K
88142		<1%	5,051	$107K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	532	$95K
64635		<1%	215	$94K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	403	$93K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	5,044	$93K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,071	$92K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,974	$91K
94060		<1%	635	$90K
71046	Radiologic examination, chest; 2 views	<1%	10,738	$90K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,025	$88K
97161		<1%	1,187	$87K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	547	$84K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,352	$82K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	621	$82K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	691	$81K
71271		<1%	411	$81K
87481		<1%	1,767	$80K
12001		<1%	459	$79K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	2,151	$75K
84439		<1%	3,057	$71K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	565	$70K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	350	$70K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	3,083	$70K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	141	$69K
70496		<1%	276	$67K
76642		<1%	490	$64K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	109	$60K
96367		<1%	730	$60K
93971		<1%	738	$59K
93017		<1%	666	$59K
87081		<1%	17,805	$55K
80076		<1%	12,332	$54K
97162		<1%	707	$54K
82607		<1%	2,714	$53K
64490		<1%	126	$52K
84702		<1%	2,394	$52K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	300	$49K
86592		<1%	1,558	$49K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	285	$49K
80055		<1%	1,697	$49K
85027		<1%	11,660	$48K
10060		<1%	276	$47K
76536		<1%	427	$47K
87653		<1%	1,093	$47K
82728		<1%	2,575	$46K
90792	Psychiatric diagnostic evaluation with medical services	<1%	176	$46K
87077		<1%	6,169	$45K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	160	$41K
86850		<1%	1,682	$40K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	20,562	$39K
94726		<1%	558	$38K
72131		<1%	596	$38K
86140		<1%	2,139	$37K
94729		<1%	543	$36K
83970		<1%	1,260	$35K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,041	$34K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	66	$33K
72100		<1%	869	$33K
96415		<1%	120	$32K
97165		<1%	523	$31K
20553		<1%	360	$30K
80069		<1%	1,809	$30K
93970		<1%	239	$30K
81001		<1%	38,829	$29K
71250		<1%	379	$29K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	42	$28K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	24,733	$28K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,282	$28K
73130		<1%	1,639	$28K
74018		<1%	903	$28K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,975	$28K
97010		<1%	801	$27K
83735		<1%	9,794	$26K
73630		<1%	1,855	$24K
83721		<1%	1,714	$24K
85014		<1%	2,576	$24K
H0012	Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)	<1%	78	$23K
70486		<1%	351	$23K
86900		<1%	1,809	$22K
87480		<1%	1,290	$22K
82950		<1%	1,684	$22K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	3,502	$21K
73560		<1%	1,624	$20K
64491		<1%	137	$19K
12011		<1%	98	$19K
84484		<1%	9,332	$19K
86039		<1%	705	$19K
76775		<1%	227	$19K
72040		<1%	426	$19K
78815	Positron emission tomography (PET) for limited area imaging	<1%	27	$18K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	1,268	$18K
76000		<1%	153	$17K
87510		<1%	1,289	$17K
87428		<1%	31,814	$17K
99214	Doctor's office visit, returning patient (more involved)	<1%	208	$16K
84460		<1%	1,661	$16K
87186		<1%	3,427	$16K
82043		<1%	2,058	$16K
73030		<1%	1,114	$15K
87340		<1%	726	$15K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	6,867	$14K
82570		<1%	1,620	$14K
85652		<1%	2,887	$14K
70491		<1%	56	$14K
73110		<1%	1,002	$14K
73610		<1%	1,466	$14K
87070		<1%	1,194	$14K
84481		<1%	853	$14K
70498		<1%	275	$13K
97116		<1%	421	$13K
95811		<1%	27	$13K
84466		<1%	1,449	$13K
81161		<1%	109	$13K
85018		<1%	2,619	$12K
87522	Neg quan hep c or qual rna	<1%	332	$12K
90715		<1%	769	$12K
76857		<1%	456	$12K
64495		<1%	58	$11K
82746		<1%	1,454	$11K
80305		<1%	4,637	$11K
84153		<1%	706	$11K
80074		<1%	540	$11K
80326		<1%	691	$11K
29581		<1%	121	$11K
83615		<1%	2,289	$10K
11102		<1%	28	$10K
83001		<1%	398	$10K
73502		<1%	595	$10K
97802		<1%	109	$10K
84146		<1%	411	$10K
83880		<1%	2,181	$10K
71045	Radiologic examination, chest; single view	<1%	5,838	$10K
J1756	Injection, iron sucrose, 1 mg	<1%	390	$10K
12002		<1%	54	$10K
93976		<1%	53	$9K
88342		<1%	633	$9K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	546	$9K
82248		<1%	2,572	$9K
86901		<1%	1,809	$9K
84403		<1%	420	$9K
81200		<1%	109	$9K
88112		<1%	228	$9K
81329		<1%	379	$8K
88307		<1%	62	$8K
86803		<1%	157	$7K
81255		<1%	109	$7K
86431		<1%	470	$7K
81251		<1%	109	$7K
81290		<1%	109	$7K
93270		<1%	40	$7K
80346		<1%	983	$7K
81330		<1%	109	$7K
0352U		<1%	481	$7K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	33	$7K
96375	Therapeutic injection; each additional sequential IV push	<1%	17,137	$7K
73080		<1%	513	$7K
81209		<1%	109	$7K
82784		<1%	445	$7K
86235		<1%	368	$7K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	263	$6K
80361		<1%	979	$6K
81260		<1%	109	$6K
96376		<1%	2,679	$6K
81242		<1%	109	$6K
83690		<1%	10,993	$6K
80365		<1%	931	$6K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	109	$6K
83550		<1%	536	$6K
97803		<1%	106	$6K
81361		<1%	109	$6K
80355		<1%	652	$6K
86364		<1%	268	$6K
80370		<1%	684	$6K
80334		<1%	521	$6K
80338		<1%	521	$6K
80331		<1%	521	$6K
80337		<1%	521	$6K
85610		<1%	3,667	$6K
86480		<1%	124	$6K
80354		<1%	573	$5K
80353		<1%	549	$5K
36430		<1%	37	$5K
82105		<1%	275	$5K
86200		<1%	369	$5K
80372		<1%	521	$5K
80344		<1%	521	$5K
80366		<1%	521	$5K
80377		<1%	521	$5K
80373		<1%	521	$5K
80357		<1%	521	$5K
80367		<1%	521	$5K
80368		<1%	521	$5K
80341		<1%	521	$5K
88304		<1%	617	$5K
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	95	$5K
84550		<1%	908	$5K
80364		<1%	844	$5K
80360		<1%	521	$5K
80348		<1%	521	$5K
80359		<1%	521	$5K
80358		<1%	521	$5K
80371		<1%	521	$5K
93880		<1%	55	$5K
84156		<1%	1,083	$5K
95816		<1%	29	$5K
64636		<1%	298	$5K
97163		<1%	67	$5K
82077		<1%	3,952	$5K
82670		<1%	147	$4K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	3,507	$4K
88341		<1%	75	$4K
87205		<1%	1,053	$4K
73590		<1%	390	$4K
77062		<1%	141	$4K
86255		<1%	252	$4K
72128		<1%	202	$4K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	9,706	$4K
73221		<1%	31	$4K
87660		<1%	573	$4K
69209		<1%	27	$4K
73700		<1%	27	$4K
J3490	Unclassified drugs	<1%	2,799	$4K
81003		<1%	8,832	$4K
82565		<1%	429	$4K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	30	$4K
80143		<1%	3,896	$4K
77065	Tomosynthesis, mammo	<1%	242	$4K
72072		<1%	125	$4K
82157		<1%	96	$4K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	919	$4K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	123	$4K
84436		<1%	189	$4K
86258		<1%	103	$3K
84100		<1%	649	$3K
86762		<1%	230	$3K
29125		<1%	112	$3K
73090		<1%	300	$3K
92526		<1%	39	$3K
82550		<1%	556	$3K
J0897	Injection, denosumab, 1 mg	<1%	12	$3K
84450		<1%	354	$3K
86160		<1%	220	$3K
84145		<1%	1,227	$3K
82677		<1%	74	$3K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	18	$3K
87147		<1%	611	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	17,863	$3K
81025		<1%	16,094	$3K
93922		<1%	24	$2K
86376		<1%	98	$2K
17000		<1%	26	$2K
80164		<1%	124	$2K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	446	$2K
20610		<1%	16	$2K
85055		<1%	113	$2K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	15	$2K
82977		<1%	268	$2K
85379		<1%	3,394	$2K
83630		<1%	152	$2K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	132	$2K
J7030	Infusion, normal saline solution , 1000 cc	<1%	28,003	$2K
83540		<1%	214	$2K
86308		<1%	347	$2K
99215	Doctor's office visit, returning patient (complex)	<1%	30	$2K
80179		<1%	3,857	$2K
76770		<1%	13	$2K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	34	$2K
92523		<1%	23	$2K
76882		<1%	32	$2K
94618		<1%	41	$2K
81243		<1%	109	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	168	$2K
71101		<1%	229	$2K
86787		<1%	45	$2K
87046		<1%	99	$2K
86618		<1%	202	$2K
76819	Fetal biophysical profile; without non-stress testing	<1%	21	$2K
77066	Tomosynthesis, mammo	<1%	158	$2K
86706		<1%	76	$2K
83605		<1%	2,250	$1K
85730		<1%	826	$1K
86812		<1%	102	$1K
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,166	$1K
80051		<1%	32	$1K
81257		<1%	17	$1K
87641		<1%	69	$1K
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	15	$989.38
82247		<1%	95	$988.02
84703		<1%	345	$980.25
82947		<1%	92	$967.90
73140		<1%	227	$943.99
77080		<1%	15	$889.80
87427		<1%	95	$874.27
76870		<1%	53	$847.69
77061		<1%	43	$829.91
84112		<1%	25	$797.06
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,715	$788.60
80081		<1%	34	$754.42
J7120	Ringers lactate infusion, up to 1000 cc	<1%	6,991	$737.89
84132		<1%	185	$736.62
82803		<1%	1,788	$720.53
82040		<1%	57	$713.56
87529		<1%	32	$694.44
86920		<1%	16	$678.90
87040		<1%	640	$668.69
86696		<1%	34	$668.19
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,355	$616.03
87493		<1%	41	$602.82
84300		<1%	145	$601.47
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	2,076	$551.92
29105		<1%	12	$518.25
84165		<1%	80	$508.07
82140		<1%	37	$460.08
87507		<1%	15	$454.15
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	8,539	$452.96
73522		<1%	14	$449.51
86800		<1%	28	$432.82
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	3,473	$429.33
J2704	Injection, propofol, 10 mg	<1%	10,371	$386.93
86694		<1%	20	$385.41
83993		<1%	28	$374.33
00813		<1%	145	$366.02
J7050	Infusion, normal saline solution, 250 cc	<1%	5,196	$355.21
84155		<1%	45	$351.56
86336		<1%	62	$341.72
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	14,573	$335.42
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,744	$306.84
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	507	$300.33
83727		<1%	17	$299.45
82951		<1%	13	$274.51
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	627	$271.39
80178		<1%	14	$264.27
87899		<1%	97	$235.37
86695		<1%	19	$231.21
84520		<1%	31	$229.92
73552		<1%	15	$227.47
84270		<1%	13	$222.41
85045		<1%	131	$222.33
82310		<1%	26	$220.34
73060		<1%	27	$217.48
D0120	Dental checkup, returning patient	<1%	12	$215.16
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	949	$212.04
96368		<1%	32	$211.94
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	2,445	$196.48
D1208	Topical application of fluoride, excluding varnish	<1%	12	$189.00
84075		<1%	31	$182.11
87338		<1%	12	$181.15
82952		<1%	13	$177.73
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	521	$174.61
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,359	$170.79
84425		<1%	16	$161.89
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	312	$136.95
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,631	$132.38
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,544	$122.99
72170		<1%	26	$112.11
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	356	$111.93
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,553	$98.75
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,115	$96.03
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,536	$95.59
J0780	Injection, prochlorperazine, up to 10 mg	<1%	598	$77.83
87486		<1%	33	$77.60
J2060	Injection, lorazepam, 2 mg	<1%	756	$71.94
82150		<1%	232	$68.41
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,675	$57.38
J2470	Injection, pantoprazole sodium, 40 mg	<1%	110	$51.61
J1644	Injection, heparin sodium, per 1000 units	<1%	572	$50.95
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,325	$47.71
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	1,031	$44.62
87581		<1%	33	$38.80
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	35	$30.65
J1940	Injection, furosemide, up to 20 mg	<1%	396	$28.81
J1630	Injection, haloperidol, up to 5 mg	<1%	455	$26.44
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	1,183	$25.64
J3411	Injection, thiamine hcl, 100 mg	<1%	86	$23.22
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,736	$21.94
J3480	Injection, potassium chloride, per 2 meq	<1%	421	$19.71
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	19	$18.60
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	45	$18.43
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	64	$17.22
82962		<1%	380	$14.95
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,999	$13.43
J2270	Injection, morphine sulfate, up to 10 mg	<1%	106	$12.88
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	9,577	$12.00
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	45	$11.38
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	51	$9.40
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	3,707	$6.44
83986		<1%	14	$6.39
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	720	$4.17
J7510	Prednisolone oral, per 5 mg	<1%	83	$3.81
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	644	$3.31
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	403	$2.75
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	242	$2.34
J1171	Injection, hydromorphone, 0.1 mg	<1%	211	$2.32
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	656	$0.62
88302		0%	18	$0.00
01810		0%	38	$0.00
77002		0%	925	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	27	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	591	$0.00
15853		0%	42	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	21	$0.00
00731		0%	204	$0.00
00812		0%	71	$0.00
86328		0%	112	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	157	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	55	$0.00
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	0%	18	$0.00
82010		0%	68	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	55	$0.00
00170	Anesthesia for intraoral procedures, including biopsy	0%	48	$0.00
00910		0%	15	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	38	$0.00
00840		0%	55	$0.00
C1758	Catheter, ureteral	0%	15	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	541	$0.00
C1769	Guide wire	0%	160	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	441	$0.00
J1815	Injection, insulin, per 5 units	0%	15	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	138	$0.00
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	0%	13	$0.00
A9270	Non-covered item or service	0%	146	$0.00
00142		0%	37	$0.00
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	0%	30	$0.00
C2627	Catheter, suprapubic/cystoscopic	0%	134	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	90	$0.00
87807		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMONTAGNESE, ROBERT (EXECUTIVE VICE PRESIDENT)